XTalks

JUNE 17, 2024

Hugel, a Korean medical aesthetics company, recently announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its botulinum toxin, Letybo (letibotulinumtoxinA-wlbg), for the treatment of glabellar lines. We are thrilled with the FDA’s approval of Letybo. What Is the Price of Letybo?

FDA Approval 52

FDA Approval Marketing Botox Clinical Trials 52

Roots Analysis

JANUARY 3, 2024

Moreover, at present, women dominate the medical aesthetics industry with over 90% market share. Medical Aesthetics encompasses a wide variety of treatments, including injectables, such as Botox, dermal fillers, chemical peels, aesthetic implants and professional laser hair removal and body contouring devices.

Filler 40

Filler Cosmetics Production Dermatology 40

XTalks

AUGUST 2, 2023

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98